Cobalt(II) complexes with the non-steroidal anti-inflammatory drug mefenamic acid in the presence or absence of nitrogen donor heterocyclic ligands (2,2'-bipyridine, 1,10-phenanthroline or pyridine) have been synthesized and characterized with physicochemical and spectroscopic techniques. The experimental data suggest that mefenamic acid acts as deprotonated monodentate ligand coordinated to Co(II) ion through a carboxylato oxygen. The crystal structures of tetrakis(methanol)bis-(mefenamato)cobalt(II), 1 and (2,2'-bipyridine)bis(methanol)bis(mefenamato)cobalt(II), 2 have been determined by X-ray crystallography. The EPR spectra of complexes 1 and 2 in frozen solution reveal that they retain their structures. UV study of the interaction of the complexes with calf-thymus DNA (CT DNA) has shown that the complexes can bind to CT DNA and bis(methanol)bis(pyridine)bis-(mefenamato)cobalt(II) exhibits the highest binding constant. Competitive study with ethidium bromide (EB) has shown that the complexes can displace the DNA-bound EB indicating that they bind to DNA in strong competition with EB. The cyclic voltammograms of the complexes recorded in dmso solution and in the presence of CT DNA in 1 : 2 dmso : buffer (containing 150 mM NaCl and 15 mM trisodium citrate at pH 7.0) solution have shown that they can bind to CT DNA by the intercalative binding mode. Mefenamic acid and its cobalt(II) complexes exhibit good binding propensity to human or bovine serum albumin protein having relatively high binding constant values. The antioxidant activity of the compounds has been evaluated indicating their high scavenging activity against hydroxyl free radicals and superoxide radicals.

No abstract

Copper(II) complexes with the non-steroidal antiinflammatory drug mefenamic acid in the presence of aqua or nitrogen donor heterocyclic ligands (2,2'-bipyridine, 1,10-phenanthroline, 2,2'-bipyridylamine or pyridine) have been synthesized and characterized. The crystal structures of [(2,2'-bipyridine)bis(mefenamato)copper(II)], 2, [(2,2'-bipyridylamine)bis(mefenamato)copper(II)], 4, and [bis(pyridine)bis(methanol)bis(mefenamato)copper(II)], 5, have been determined by X-ray crystallography. UV study of the interaction of the complexes with calf-thymus DNA (CT DNA) has shown that the complexes can bind to CT DNA and [bis(aqua)tetrakis(mefenamato)dicopper(II)] exhibits the highest binding constant to CT DNA. The cyclic voltammograms of the complexes in the presence of CT DNA solution have shown that the complexes can bind to CT DNA by the intercalative binding mode verified also by DNA solution viscosity measurements. Competitive studies with ethidium bromide (EB) indicate that the complexes can displace the DNA-bound EB suggesting strong competition with EB. Mefenamic acid and its complexes exhibit good binding propensity to human or bovine serum albumin protein having relatively high binding constant values. All the compounds have been tested for their antioxidant and free radical scavenging activity as well as for their in vitro inhibitory activity against soybean lipoxygenase showing significant activity.

Citrate is abundantly encountered in biological fluids as a natural metal ion chelator. Vanadium participates in biological processes as a catalyst in the active sites of metalloenzymes, as a metabolic regulator, as a mitogenic activator, and as an insulin-mimicking agent. Thus, vanadium chemistry with natural chelators, such as citrate, may have immediate implications on its role in a cellular milieu, and its action as a biological agent. In an effort to comprehend the aqueous chemistry of one of vanadium's oxidation states, namely, V(IV), implicated in its biological activity, reactions of VCl(3) and citric acid were pursued in water and led to V(IV)-citrate complexes, the nature and properties of which depend strongly on the solution pH. Analytical, FT-IR, UV/vis, EPR, and magnetic susceptibility data supported the formulation of X(4)[[VO(H(-1)Cit)](2)] x nH(2)O (H(-1)Cit = C(6)H(4)O(7)(4-); X = K(+), n = 6 (1); X = Na(+), n = 12 (2); X = NH(4)(+), n = 2 (3)) (pH approximately 8) and X(3)[[V(2)O(2)(H(-1)Cit)(Cit)]] x nH(2)O (X = K(+), n = 7 (4)) (pH approximately 5). Complex 2 crystallizes in space group P2(1)/c, a = 11.3335(9) A, b = 15.788(1) A, c = 8.6960(6) A, beta = 104.874(3) degrees, V = 1503.8(2), Z = 2. Complex 3 crystallizes in space group P one macro, a = 9.405(1) A, b = 10.007(1) A, c = 13.983(2) A, alpha = 76.358(4) degrees, beta = 84.056(4) degrees, gamma = 66.102(4) degrees, V = 1169.2(3), Z = 2. Complex 4 crystallizes in space group P2(1)nb, a = 9.679(4) A, b = 19.618(8) A, c = 28.30(1) A, V = 5374.0(4), Z = 8. The X-ray structures of 1-4 are V(2)O(2) dimers, with the citrate displaying varying coordination numbers and modes. 1 exhibits a small ferromagnetic interaction, whereas 4 exhibits an antiferromagnetic interaction between the V(IV) ions. 1 and 4 interconvert with pH, thus rendering the pH a determining factor promoting variable structural, electronic, and magnetic properties in V(IV)-citrate species. The observed aqueous behavior of 1-4 is consistent with past solution speciation studies, and contributes to the understanding of significant aspects of the biologically relevant vanadium(IV)-citrate chemistry.

The 3,5-di-tert-butyl-catecholato and 9,10-phenanthrenecatecholato adducts of the cobalt-tetraazamacrocycle complex Co(Me(4)cyclam)(2+) (Me(4)cyclam = 1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane) were synthesized and oxidized. The oxidation reaction products were isolated in the solid state as hexafluorophosphate derivatives. Both these complexes can be formulated as 1:1 cobalt(II)-semiquinonato complexes, that is, Co(Me(4)cyclam)(DBSQ)PF(6) (1) and Co(Me(4)cyclam)(PhSQ)PF(6) (2), in the temperature range 4-300 K, in striking contrast with the charge distribution found in similar adducts formed by related tetraazamacrocycles. The synthesis strategy and the structural, spectroscopic, and magnetic properties are reported and discussed. The crystallographic data for 2 are as follows: monoclinic, space group P2(1)/a, nomicron. 14, a = 14.087(4) A, b = 15.873(4) A, c = 14.263 (7) A, alpha = 89.91(3) degrees, beta = 107.34(2) degrees, gamma = 90.08(2) degrees, Z = 4. Both these complexes are characterized by triplet electronic ground states arising from the antiferromagnetic coupling between the high-spin d(7) metal ion and the radical ligand.